Tsukioka T, Takemura S, Minamiyama Y, Mizuguchi S, Toda M, Okada S
It was found that the ability of MSH in reducing dermal fibroblast proliferation was diminished by the presence of MC1R gene variants like R163Q, R151C and V60L (185), strongly suggesting the need to incorporate pharmacogenomics approaches applied to MC 1 -based therapies to deliver personalised therapies
You can, however, select an extended insurance plan that covers the injection plus the appointment fees and specialized treatment costs related to vitamin B12 deficiency
If you're on immunosuppressive medications (biologics, corticosteroids), discuss with your doctor before starting any peptide protocol
Its important to discuss with a healthcare provider if severe or consistent side effects